These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34329780)

  • 1. In Situ biomimetic Nanoformulation for metastatic cancer immunotherapy.
    Zhang X; Zhang Y; Zheng H; He Y; Jia H; Zhang L; Lin C; Chen S; Zheng J; Yang Q; Liu T; Pan X; Zhang H; Wang C; Ren L; Shan W
    Acta Biomater; 2021 Oct; 134():633-648. PubMed ID: 34329780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesive property and mechanism of silkworm egg glue protein.
    Lei Y; Guo K; Zhang Y; Zhang X; Qin L; Wang X; Zhu H; Guo Y; Yang W; Li B; Xia Q; Zhao P; Dong Z
    Acta Biomater; 2021 Oct; 134():499-512. PubMed ID: 34311106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1.
    Wang H; Tang Y; Fang Y; Zhang M; Wang H; He Z; Wang B; Xu Q; Huang Y
    Nano Lett; 2019 May; 19(5):2935-2944. PubMed ID: 30950276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.
    Saenger YM; Li Y; Chiou KC; Chan B; Rizzuto G; Terzulli SL; Merghoub T; Houghton AN; Wolchok JD
    Cancer Res; 2008 Dec; 68(23):9884-91. PubMed ID: 19047169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging β-Adrenergic Receptor Signaling Blockade for Improved Cancer Immunotherapy Through Biomimetic Nanovaccine.
    Yang C; He Y; Chen F; Zhang F; Shao D; Wang Z
    Small; 2023 Apr; 19(14):e2207029. PubMed ID: 36703529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Situ Cocktail Nanovaccine for Cancer Immunotherapy.
    Liu M; Xie D; Hu D; Zhang R; Wang Y; Tang L; Zhou B; Zhao B; Yang L
    Adv Sci (Weinh); 2023 Nov; 10(31):e2207697. PubMed ID: 37740439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
    Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
    Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necroptotic cancer cells-mimicry nanovaccine boosts anti-tumor immunity with tailored immune-stimulatory modality.
    Kang T; Huang Y; Zhu Q; Cheng H; Pei Y; Feng J; Xu M; Jiang G; Song Q; Jiang T; Chen H; Gao X; Chen J
    Biomaterials; 2018 May; 164():80-97. PubMed ID: 29499438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer.
    Ito F; Ku AW; Bucsek MJ; Muhitch JB; Vardam-Kaur T; Kim M; Fisher DT; Camoriano M; Khoury T; Skitzki JJ; Gollnick SO; Evans SS
    PLoS One; 2015; 10(11):e0143370. PubMed ID: 26599402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.
    Jackaman C; Bundell CS; Kinnear BF; Smith AM; Filion P; van Hagen D; Robinson BW; Nelson DJ
    J Immunol; 2003 Nov; 171(10):5051-63. PubMed ID: 14607902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4
    He K; Liu P; Xu LX
    Cell Death Dis; 2017 Mar; 8(3):e2703. PubMed ID: 28333145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil infiltration and whole-cell vaccine elicited by N-dihydrogalactochitosan combined with NIR phototherapy to enhance antitumor immune response and T cell immune memory.
    Qi S; Lu L; Zhou F; Chen Y; Xu M; Chen L; Yu X; Chen WR; Zhang Z
    Theranostics; 2020; 10(4):1814-1832. PubMed ID: 32042338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Progenitor Exhausted Tissue-Resident Memory CD8
    León-Letelier RA; Castro-Medina DI; Badillo-Godinez O; Tepale-Segura A; Huanosta-Murillo E; Aguilar-Flores C; De León-Rodríguez SG; Mantilla A; Fuentes-Pananá EM; López-Macías C; Bonifaz LC
    Front Immunol; 2020; 11():583382. PubMed ID: 33240271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
    Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
    Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple self-adjuvanting biomimetic nanovaccine self-assembled with the conjugate of phospholipids and nucleotides can induce a strong cancer immunotherapeutic effect.
    Liu D; Liu J; Ma B; Deng B; Leng X; Kong D; Liu L
    Biomater Sci; 2021 Jan; 9(1):84-92. PubMed ID: 33016303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-responsive micellar JQ1 induces enhanced BET protein inhibition and immunotherapy of malignant tumors.
    Zhang Z; Zhang Q; Xie J; Zhong Z; Deng C
    Biomater Sci; 2021 Oct; 9(20):6915-6926. PubMed ID: 34524279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A TLR3-Specific Adjuvant Relieves Innate Resistance to PD-L1 Blockade without Cytokine Toxicity in Tumor Vaccine Immunotherapy.
    Takeda Y; Kataoka K; Yamagishi J; Ogawa S; Seya T; Matsumoto M
    Cell Rep; 2017 May; 19(9):1874-1887. PubMed ID: 28564605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
    Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
    Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary and metastatic breast tumors cross-talk to influence immunotherapy responses.
    Oliver AJ; Keam SP; von Scheidt B; Zanker DJ; Harrison AJ; Tantalo DG; Darcy PK; Kershaw MH; Slaney CY
    Oncoimmunology; 2020 Aug; 9(1):1802979. PubMed ID: 32939322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic DC Activation Modulates the Tumor Microenvironment and Shapes the Long-Lived Tumor-Specific Memory Mediated by CD8+ T Cells.
    Shimizu K; Yamasaki S; Shinga J; Sato Y; Watanabe T; Ohara O; Kuzushima K; Yagita H; Komuro Y; Asakura M; Fujii S
    Cancer Res; 2016 Jul; 76(13):3756-66. PubMed ID: 27371739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.